{"id":"iopromide-ultravist","safety":{"commonSideEffects":[{"rate":null,"effect":"Contrast-induced nephropathy"},{"rate":null,"effect":"Allergic reactions (mild to severe)"},{"rate":null,"effect":"Nausea and vomiting"},{"rate":null,"effect":"Flushing and warmth sensation"},{"rate":null,"effect":"Hypersensitivity reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Iopromide contains iodine atoms that absorb X-rays more effectively than surrounding soft tissues, creating contrast in radiographic images. As a non-ionic contrast agent, it has lower osmolarity than ionic agents, which reduces the risk of adverse reactions and renal toxicity. It is used intravenously to opacify vascular structures and organs during diagnostic imaging.","oneSentence":"Iopromide is a non-ionic, low-osmolarity iodinated contrast medium that increases radiodensity in blood vessels and tissues to enhance visualization during radiographic imaging procedures.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:50:14.979Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Contrast enhancement in angiography and vascular imaging"},{"name":"Contrast enhancement in computed tomography (CT) imaging"},{"name":"Contrast enhancement in urography and other radiographic procedures"}]},"trialDetails":[{"nctId":"NCT07391787","phase":"","title":"Low-acid Contrast Media for Preventing Post ERCP Pancreatitis","status":"COMPLETED","sponsor":"Shandong University","startDate":"2025-08-01","conditions":"Post-ERCP Acute Pancreatitis","enrollment":3979},{"nctId":"NCT06475066","phase":"NA","title":"Clinical Effectiveness of CEM in Diagnosis of Additional Findings at Preoperative Breast Magnetic Resonance Imaging","status":"NOT_YET_RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2024-07-01","conditions":"Breast Cancer","enrollment":320},{"nctId":"NCT04561739","phase":"NA","title":"Paclitaxel-coated Balloon for Treatment of De-novo Non-complex Coronary Artery Lesions","status":"ACTIVE_NOT_RECRUITING","sponsor":"Xijing Hospital","startDate":"2021-02-01","conditions":"De Novo Stenosis, Coronary Artery Disease","enrollment":2272},{"nctId":"NCT05428397","phase":"","title":"A Study, Called UV Population, to Learn More About the Safety of the Study Drug Ultravist, Which is Given to Get Clearer X-ray Pictures, in People of Different Sexes, Races, and From Different Countries/Regions","status":"COMPLETED","sponsor":"Bayer","startDate":"2022-06-30","conditions":"Contrast Enhanced X-ray Based Examination","enrollment":152233},{"nctId":"NCT06033573","phase":"NA","title":"Preoperative Assessment of Pathological Nipple Discharge With Delayed Ductal Imaging of Contrast-enhanced Mammography","status":"UNKNOWN","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2023-08-01","conditions":"Nipple Discharge","enrollment":60},{"nctId":"NCT01943643","phase":"NA","title":"Multislice CT Angiography of Coronary Bifurcations and Outcomes After Intervention","status":"COMPLETED","sponsor":"Clinical Hospital Center Zemun","startDate":"2013-09","conditions":"Coronary Artery Disease","enrollment":70},{"nctId":"NCT05786846","phase":"","title":"Serum Thyroid Function After Iodinated Contrast Administration","status":"UNKNOWN","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2023-02-15","conditions":"Thyroid Dysfunction","enrollment":400},{"nctId":"NCT01140204","phase":"PHASE1, PHASE2","title":"Short-Term Exposure to Lipophilic Anti-proliferative Drugs Delivered by Angiographic Contrast Media","status":"COMPLETED","sponsor":"University Hospital, Saarland","startDate":"2003-03","conditions":"Coronary Artery Disease","enrollment":32},{"nctId":"NCT05778929","phase":"","title":"Radiomic fEatures of Pancreas From Contrast Enhanced CT Image Predict One-Year RecUrrence Risk of Acute PancReatitis","status":"UNKNOWN","sponsor":"Peking University People's Hospital","startDate":"2023-04-01","conditions":"Pancreatitis, Chronic","enrollment":694},{"nctId":"NCT05729490","phase":"NA","title":"Techniques and Pitfalls of Multi-Slice CT Coronary Angiography","status":"UNKNOWN","sponsor":"Sohag University","startDate":"2023-01-01","conditions":"Computed Tomography Angiography, Coronary Artery Disease","enrollment":60},{"nctId":"NCT05666375","phase":"NA","title":"Percutaneous Translumbar Vs Transhepatic Permcath","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-01-01","conditions":"End Stage Renal Disease","enrollment":52},{"nctId":"NCT01735825","phase":"NA","title":"Treatment of Coronary In-Stent Restenosis","status":"COMPLETED","sponsor":"University Hospital Ostrava","startDate":"2012-01","conditions":"Restenosis","enrollment":199},{"nctId":"NCT03667313","phase":"PHASE3","title":"Treatment of In-Stent Restenosis 2 Study","status":"COMPLETED","sponsor":"University Hospital Ostrava","startDate":"2018-10-01","conditions":"Coronary Restenosis","enrollment":200},{"nctId":"NCT05516446","phase":"NA","title":"Drug Eluting Balloon Angioplasty Versus Everolimus Platinum Chrome Stent","status":"UNKNOWN","sponsor":"General Administration of Military Health, Tunisia","startDate":"2021-08-25","conditions":"Percutaneous Coronary Intervention (PCI), Coronary Artery Disease (CAD), De Novo Stenosis","enrollment":290},{"nctId":"NCT03631771","phase":"PHASE4","title":"Pediatric Risk of Hypothyroidism With Iodinated Contrast Media","status":"WITHDRAWN","sponsor":"GE Healthcare","startDate":"2022-03","conditions":"Hypothyroidism","enrollment":""},{"nctId":"NCT04908826","phase":"NA","title":"Comparison of Icg's Route of Administration During Laparoscopic Cholecystectomy","status":"UNKNOWN","sponsor":"Aristotle University Of Thessaloniki","startDate":"2022-01-03","conditions":"Laparoscopic; Cholecystectomy, Cholelithiasis; Bile Duct, Choledocholithiasis","enrollment":240},{"nctId":"NCT04605471","phase":"","title":"A Study to Learn More About the Safety of Ultravist in Children and in the Elderly","status":"COMPLETED","sponsor":"Bayer","startDate":"2020-10-31","conditions":"Hypersensitivity","enrollment":132850},{"nctId":"NCT01703650","phase":"","title":"Role of Perfusion CT in Pancreatic Cancer","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2012-11","conditions":"Adenocarcinoma, Pancreas, Neuroendocrine Carcinoma of Pancreas","enrollment":48},{"nctId":"NCT03622801","phase":"","title":"Study on the Risk of Allergy-like Reactions After Intra-arterial or Intra-venous Injection of the Marketed X-ray Contrast Medium Iopromid","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-10-12","conditions":"Contrast Medium","enrollment":133331},{"nctId":"NCT03179592","phase":"","title":"VOLtage-based Contrast Media AdaptatioN in Coronary Computed Tomography Angiography","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2017-03-22","conditions":"Coronary Artery Disease, Cardiovascular Diseases","enrollment":120},{"nctId":"NCT00335101","phase":"PHASE4","title":"Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Undergoing Coronary Angiography","status":"WITHDRAWN","sponsor":"GE Healthcare","startDate":"2006-06","conditions":"Coronary Artery Disease (CAD), Renal Impairment, Diabetes Mellitus","enrollment":""},{"nctId":"NCT03292354","phase":"NA","title":"Personalization of CM Injection Protocols in Coronary Computed Tomographic Angiography","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2017-04-11","conditions":"Coronary Artery Calcification, Cardiac Disease","enrollment":327},{"nctId":"NCT02840903","phase":"","title":"A Non-interventional Study to Observe the Computed Tomographic Angiography Image Quality With Different Contrast Media Injection Protocols Under Different Computed Tomography Machines Parameters Setting","status":"COMPLETED","sponsor":"Bayer","startDate":"2016-07-26","conditions":"Angiography, Multidetector Computed Tomography","enrollment":1214},{"nctId":"NCT03448302","phase":"","title":"Computed Tomography Perfusion Colorectal Cancer With Tumor Grade","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2018-03-10","conditions":"Colo-rectal Cancer","enrollment":50},{"nctId":"NCT01607489","phase":"NA","title":"Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography","status":"COMPLETED","sponsor":"Medical University of Graz","startDate":"2011-06","conditions":"Pulmonary Arterial Hypertension","enrollment":25},{"nctId":"NCT01829672","phase":"NA","title":"Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography","status":"COMPLETED","sponsor":"Medical University of Graz","startDate":"2013-03","conditions":"Pulmonary Arterial Hypertension","enrollment":55},{"nctId":"NCT03110068","phase":"","title":"Preoperative Estimation of Microvascular Invasion in Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"Ming Kuang","startDate":"2017-04-10","conditions":"Hepatocellular Carcinoma","enrollment":370},{"nctId":"NCT02380209","phase":"EARLY_PHASE1","title":"An Early Phase Clinical Trial to Evaluate the Feasibility of CEST MRI in Patients With Early Stage Breast Cancer","status":"TERMINATED","sponsor":"University of Arizona","startDate":"2014-08","conditions":"Breast Cancer","enrollment":8},{"nctId":"NCT01255722","phase":"PHASE4","title":"Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography","status":"COMPLETED","sponsor":"Guerbet","startDate":"2010-11","conditions":"Coronary Artery Disease","enrollment":468},{"nctId":"NCT01415414","phase":"","title":"Observational Study of Ultravist in Patients Requiring CECT","status":"COMPLETED","sponsor":"Bayer","startDate":"2011-09","conditions":"Diagnostic Imaging","enrollment":11660},{"nctId":"NCT00244140","phase":"PHASE3","title":"Ultravist: Safety and Efficacy in Computed Tomography of Head and Body","status":"COMPLETED","sponsor":"Bayer","startDate":"2005-10","conditions":"Computed Tomography, Diagnostic Imaging","enrollment":435},{"nctId":"NCT01654354","phase":"","title":"Comparison of NEOVIST 370 INJ.(Iopromide 768.86mg) With Ultravist 370 INJ.(Iopromide 768.86mg) in Abdominal CT","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2012-07","conditions":"Abdominal CT","enrollment":104},{"nctId":"NCT01580046","phase":"PHASE4","title":"Renal Toxicity of Iodixanol and Iopromide in Patients With Renal Dysfunction","status":"UNKNOWN","sponsor":"Yong Huo","startDate":"2012-04","conditions":"Kidney Failure, Chronic","enrollment":200},{"nctId":"NCT01114295","phase":"NA","title":"Computed Tomography Enterography (CTE) Versus Capsule Endoscopy for Overt, Obscure Gastrointestinal (GI) Bleeding","status":"WITHDRAWN","sponsor":"Brigham and Women's Hospital","startDate":"2010-03","conditions":"Recurrent Gastrointestinal Bleeding","enrollment":""},{"nctId":"NCT01206257","phase":"","title":"The Safety and toleRability of UltraviSt in Patients Undergoing Cardiac CaTheterization (TRUST)","status":"COMPLETED","sponsor":"Bayer","startDate":"2010-08","conditions":"Angiocardiography","enrollment":17513},{"nctId":"NCT00724659","phase":"NA","title":"Pre and Post Arthrogram Ultrasound Images of Joints","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2004-09","conditions":"Joint Abnormalities","enrollment":9},{"nctId":"NCT01469026","phase":"PHASE4","title":"CUP Project PET/CT","status":"UNKNOWN","sponsor":"Odense University Hospital","startDate":"2011-11","conditions":"Metastasising Cancer of Unknown Primary","enrollment":220},{"nctId":"NCT00926562","phase":"PHASE4","title":"A Safety Comparison of Iopromide and Iodixanol in Renal Impaired Patients","status":"COMPLETED","sponsor":"Chinese PLA General Hospital","startDate":"2009-02","conditions":"Kidney Failure, Chronic","enrollment":592},{"nctId":"NCT00876083","phase":"","title":"PMS Study Ultravist-IMAGE, IoproMide (UltrAvist) to Gain Further Information on Tolerability and Safety in X-ray Examination","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-03","conditions":"Diagnostic Imaging","enrollment":44920},{"nctId":"NCT00827788","phase":"PHASE4","title":"Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI)","status":"COMPLETED","sponsor":"Ospedale San Donato","startDate":"2008-12","conditions":"Contrast Induced Nephropathy, Acute Myocardial Infarction","enrollment":432},{"nctId":"NCT00823628","phase":"PHASE4","title":"Contrast-medium Induced Nephrotoxicity in Patients Undergoing Coronary Angiography - Iodixanol Versus Iopromide","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2009-02","conditions":"Chronic Renal Insufficiency, Coronary Angiography","enrollment":420},{"nctId":"NCT00154648","phase":"PHASE4","title":"CE-MRA Using Gadovist in Comparison to IA DSA Using Ultravist","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2005-06","conditions":"Angiography, Digital Subtraction, Magnetic Resonance Angiography","enrollment":40}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"ASCITES"},{"count":1,"reaction":"CARDIAC FAILURE"},{"count":1,"reaction":"DEPRESSED LEVEL OF CONSCIOUSNESS"},{"count":1,"reaction":"DIABETES MELLITUS INADEQUATE CONTROL"},{"count":1,"reaction":"DIALYSIS"},{"count":1,"reaction":"FLUID OVERLOAD"},{"count":1,"reaction":"MIOSIS"},{"count":1,"reaction":"MULTI-ORGAN FAILURE"},{"count":1,"reaction":"NEPHROPATHY TOXIC"},{"count":1,"reaction":"RENAL FAILURE"}],"_approvalHistory":[],"publicationCount":45,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Ultravist"],"phase":"marketed","status":"active","brandName":"Iopromide (Ultravist)","genericName":"Iopromide (Ultravist)","companyName":"Chinese PLA General Hospital","companyId":"chinese-pla-general-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Iopromide is a non-ionic, low-osmolarity iodinated contrast medium that increases radiodensity in blood vessels and tissues to enhance visualization during radiographic imaging procedures. Used for Contrast enhancement in angiography and vascular imaging, Contrast enhancement in computed tomography (CT) imaging, Contrast enhancement in urography and other radiographic procedures.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}